Source: Pulse2.0

Range Bio: Range Biotechnologies: Developing Translational Proteomics For The Next Human Health Stage

Range Biotechnologies is a company developing translational proteomics (proteins) for the next stage of human health. Pulse 2.0 interviewed Range Biotechnologies co-founder and CEO Brandon Wilson, Ph.D., to learn more. The post Range Biotechnologies: Developing Translational Proteomics For The Next Human Health Stage appeared first on Pulse 2.0.

Read full article »

Range Bio's Competitors | Range Bio's News | Range Bio's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

1-25

Co-Founder & CEO

Brandon Wilson

CEO Approval Rating

90/100

Range Bio is a California-based biotechnology firm that develops a platform offering solutions such as proteomics analysis and drug discovery for the healthcare industry.